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A
 
BSTRACT
 
We report the detailed clinical course of a 47-year-old
woman with aspirin-induced asthma in which non-
steroidal anti-inflammatory drug (NSAID) intolerance
developed over a 3 year period. The patient had mild
asthma and was admitted with a femoral fracture in
August 1996. Although she was given NSAIDs, includ-
ing rectal diclofenac and oral loxoprofen, there was
no worsening of asthma. After discharge, she was fol-
lowed as having NSAID-tolerant asthma. When she
developed perennial rhinitis and anosmia subsequent
to an upper respiratory tract infection, asthma control
was well maintained. Later, she experienced three
episodes of severe asthmatic attacks after intake of
aspirin or ketoprofen. Thus, we investigated her NSAID
tolerability in September 1999. Sodium tolmetin inhal-
ation challenge demonstrated a positive reaction,
leading to the diagnosis of aspirin-induced asthma.
Open challenges with loxoprofen and diclofenac also
provoked positive reactions. The present case illus-
trates the potential variability of aspirin-induced asthma.
Aspirin or NSAIDs challenge tests should be performed
when nasal symptoms, particularly anosmia, develop
or worsen.
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I
 
NTRODUCTION
 
Some patients with aspirin-induced asthma have a past
history of taking non-steroidal anti-inflammatory drugs
(NSAIDs) safely.
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 We report herein on an uncommon
variant of the development of aspirin-induced asthma.
 
C
 
ASE
 
 
 
REPORT
 
A 47-year-old woman was admitted to Fujinomiya City
General Hospital with left femoral fracture in August
1996. She had a 5 year history of asthma and had been
given a prescription for 200 mg theophylline, 20 
 
µ
 
g
clenbuterol, 1 mg betamethasone, 8 mg chlorphenira-
mine and inhaled salbutamol on an as-needed basis at
a local clinic. She was given NSAIDs, including 50 mg
rectal diclofenac on an as-needed basis or 60 mg oral
loxoprofen three times a day, as analgesics by an
orthopedist. However, there was no worsening of asth-
matic symptoms since the initial administration. After
discharge, the treatment regimen was changed to
400 
 
µ
 
g beclomethasone dipropionate, 400 mg theo-
phylline and 450 mg pranlukast. However, ingestion of
60 mg loxoprofen three times a day did not provoke any
symptoms and the patient was followed as having
NSAID-tolerant asthma. After she developed symptoms
of perennial rhinitis over a period of months, she began
to experience anosmia subsequent to an upper res-
piratory infection in August 1997 and the diagnosis of
chronic sinusitis was made. However, asthma control
was well maintained and there were no NSAIDs taken
since February 1998. In September 1998, she experi-
enced a severe asthmatic attack after the ingestion of
330 mg aspirin. In July and September 1999, similar
episodes occurred after ingestion of aspirin and the
administration of 50 mg ketoprofen intramuscularly,
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respectively. Thus, we needed to investigate her NSAID
tolerability.
Laboratory data demonstrated a white blood cell
count of 4300 /
 
µ
 
L, with 13% eosinophils, and a total IgE
of 140 IU/mL. Specific IgE analysis was negative for
common inhalant allergens. The forced expiratory volume
in 1 s (FEV
 
1
 
) was 2.49 L (104.6% of predicted values)
and the provocative concentration of methacholine
causing a 20% fall in FEV
 
1
 
 was 2.97 mg/mL. Challenge
tests with NSAIDs were performed after informed consent
was obtained. Sodium tolmetin inhalation challenge
demonstrated that the threshold concentration causing a
greater than 20% fall in FEV
 
1
 
 was 0.5%, leading to the
diagnosis of aspirin-induced asthma. Open oral chal-
lenge with 30 mg loxoprofen and rectal challenge with
12.5 mg diclofenac provoked dyspnea, conjunctival
injection, facial flushing and a greater than 20% fall in
FEV
 
1
 
 70 and 120 min after administration, respectively.
This patient has been instructed not to ingest any form of
NSAID since that time.
The minimal concentration of NSAID causing an
adverse reaction had decreased to less than one-quarter
for diclofenac and half for loxoprofen. Some medica-
tions, including corticosteroids and antihistamines, atten-
uate aspirin-induced reactions, leading to false-negative
results on aspirin challenge tests.
 
2
 
 However, NSAIDs did
not provoke any symptoms without an oral corticosteroid
or antihistamine in our patient. Furthermore, it was
unlikely that desensitization of NSAIDs had occurred by
chance because neither medication was administered
daily during the course. We speculate that NSAID intoler-
ance developed after the appearance of anosmia sub-
sequent to a viral infection, which is reported to be the
typical natural course of aspirin-induced asthma in the
literature.
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 However, we rarely encounter the conversion
of NSAID-tolerant asthma to NSAID-intolerant asthma
over a 3 year period. This case illustrates the potential
variability of aspirin-induced asthma. Aspirin or NSAIDs
challenge tests should be performed when nasal symp-
toms, particularly anosmia, develop or worsen.
 
R
 
EFERENCES
 
1 Pleskow WW, Stevenson DD, Mathison DA, Simon RA,
Schatz M, Zeiger RS. Aspirin-sensitive rhinosinusitis/
asthma: Spectrum of adverse reactions to aspirin.
 
J. Allergy Clin. Immunol.
 
 1983; 
 
71
 
: 574–9.
2 Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A.
Oral and bronchial provocation tests with aspirin for
diagnosis of aspirin-induced asthma. 
 
Eur. Respir. J.
 
 2000;
 
15
 
: 863–9.
3 Szczeklik A, Nizankowska E, Duplaga M. Natural history
of aspirin-induced asthma. 
 
Eur. Respir. J.
 
 2000; 
 
16
 
:
432–6.
4 Pilar Berges-Gimeno M, Simon RA, Stevenson DD. The
natural history and clinical characteristics of aspirin-
exacerbated respiratory disease. 
 
Ann. Allergy Asthma
Immunol.
 
 2002; 
 
89
 
: 474–8.
